Free Trial

Prestige Consumer Healthcare (PBH) Competitors

Prestige Consumer Healthcare logo
$84.88 +0.47 (+0.55%)
Closing price 03:59 PM Eastern
Extended Trading
$85.04 +0.16 (+0.19%)
As of 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, ITCI, and UTHR

Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Intra-Cellular Therapies (ITCI), and United Therapeutics (UTHR).

Prestige Consumer Healthcare vs.

Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Prestige Consumer Healthcare has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.6% of Inter Parfums shares are owned by institutional investors. 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 43.9% of Inter Parfums shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prestige Consumer Healthcare$1.14B3.69$209.34M$4.2919.82
Inter Parfums$1.47B2.86$152.65M$5.1425.39

Prestige Consumer Healthcare has a net margin of 19.13% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Prestige Consumer Healthcare19.13% 12.36% 6.39%
Inter Parfums 10.60%16.34%10.82%

Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.2%. Inter Parfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.5%. Prestige Consumer Healthcare pays out 44.3% of its earnings in the form of a dividend. Inter Parfums pays out 62.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Inter Parfums has increased its dividend for 4 consecutive years. Inter Parfums is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Prestige Consumer Healthcare received 27 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.14% of users gave Prestige Consumer Healthcare an outperform vote while only 65.24% of users gave Inter Parfums an outperform vote.

CompanyUnderperformOutperform
Prestige Consumer HealthcareOutperform Votes
498
70.14%
Underperform Votes
212
29.86%
Inter ParfumsOutperform Votes
471
65.24%
Underperform Votes
251
34.76%

Prestige Consumer Healthcare currently has a consensus target price of $93.33, suggesting a potential upside of 9.78%. Inter Parfums has a consensus target price of $157.60, suggesting a potential upside of 20.78%. Given Inter Parfums' stronger consensus rating and higher possible upside, analysts plainly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prestige Consumer Healthcare
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Inter Parfums
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Inter Parfums had 4 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 11 mentions for Inter Parfums and 7 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.29 beat Inter Parfums' score of 0.93 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prestige Consumer Healthcare
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inter Parfums
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Inter Parfums beats Prestige Consumer Healthcare on 13 of the 21 factors compared between the two stocks.

Get Prestige Consumer Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBH vs. The Competition

MetricPrestige Consumer HealthcarePharmaceutical IndustryMedical SectorNYSE Exchange
Market Cap$4.20B$6.49B$5.33B$19.31B
Dividend YieldN/A2.64%5.21%3.83%
P/E Ratio19.899.1226.8534.55
Price / Sales3.69256.15388.7434.91
Price / Cash17.0365.8538.2517.51
Price / Book2.366.436.764.68
Net Income$209.34M$144.21M$3.23B$1.02B
7 Day Performance-2.40%2.25%1.71%-1.96%
1 Month Performance6.10%4.39%11.16%7.26%
1 Year Performance31.35%-2.71%17.17%3.95%

Prestige Consumer Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBH
Prestige Consumer Healthcare
3.7022 of 5 stars
$84.89
+0.6%
$93.33
+10.0%
+29.9%$4.19B$1.14B19.88540Positive News
IPAR
Inter Parfums
3.9716 of 5 stars
$128.17
+1.1%
$157.60
+23.0%
+8.2%$4.12B$1.47B27.50530Positive News
Analyst Revision
HLF
Herbalife
4.5029 of 5 stars
$6.93
-1.8%
$11.50
+65.9%
-39.6%$705.80M$4.95B2.7810,100Analyst Downgrade
USNA
USANA Health Sciences
4.281 of 5 stars
$30.07
-0.7%
$36.00
+19.7%
-40.3%$559.99M$876.24M10.631,900Positive News
Analyst Upgrade
NUS
Nu Skin Enterprises
2.9617 of 5 stars
$7.47
-1.5%
$6.88
-8.0%
-45.5%$371.43M$1.68B-2.5313,400Positive News
NATR
Nature's Sunshine Products
2.7572 of 5 stars
$14.88
+0.1%
$18.33
+23.2%
-8.8%$273.06M$456.62M16.91850
MED
Medifast
3.381 of 5 stars
$13.98
-0.1%
$16.50
+18.0%
-45.6%$153.65M$543.45M77.67870Positive News
Analyst Revision
VERU
Veru
1.6571 of 5 stars
$0.52
+0.1%
$4.00
+669.4%
-64.8%$76.21M$16.89M-2.00230Analyst Revision
EL
Estée Lauder Companies
4.3409 of 5 stars
$65.35
+0.3%
$75.20
+15.1%
-52.1%$23.51B$14.79B-33.5163,000Positive News
ITCI
Intra-Cellular Therapies
0.875 of 5 stars
$131.87
flat
$109.70
-16.8%
N/A$14.05B$680.50M-151.57560News Coverage
UTHR
United Therapeutics
4.9796 of 5 stars
$305.31
0.0%
$392.00
+28.4%
+12.5%$13.77B$2.99B13.41980Positive News
Analyst Revision

Related Companies and Tools


This page (NYSE:PBH) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners